Single-Institute Review of HER-2/Neu-Positive Invasive Lobular Breast Carcinoma in an Arab Population

Por Osmani, Asif Husain, Tulbah, Asma M., Alsayed, Adher, AlShanqeeti, Ali, Al-Twegieri, Taher, Ajarim, Dahish S., Suleman, Kausar
Publicado no Am J Case Rep (2021)

Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: The Saudi Arabia experience

Por Alshabanah Mohamed, Al Malik Osama, Tulbah Asma, Alsayed Adher, Al-Zahrani Ali, Ajarim Dahish, Dermime Said, Elkum Naser, Ezzat Adnan, Al-Tweigeri Taher
Publicado em 2007-12-01

Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: The Saudi Arabia experience

Por Elkum, Naser, Dermime, Said, Ajarim, Dahish, Al-Zahrani, Ali, Alsayed, Adher, Tulbah, Asma, Al Malik, Osama, Alshabanah, Mohamed, Ezzat, Adnan, Al-Tweigeri, Taher
Publicado em 2007

Trastuzumab, Pertuzumab, and Docetaxel as the First Line for HER-2-Positive Metastatic Breast Cancer among Arabs

Por Suleman, Kausar, Mushtaq, Ali Hassan, Haque, Emaan, Badran, Ahmed Ali, Ajarim, Dahish, Elashwah, Ahmed Mohammed, Gad, Ahmed Mostafa, Abdelsamad, Amgad Shaheen, Omar, Ayman, Khan, Khurshid Ahmed, Al-Tweigeri, Taher, Elshentenawy, Ayman, Alsayed, Adher
Publicado no Breast Care (Basel) (2021)